Condition: Endometrial Cancer · Sponsor: Canadian Cancer Trials Group
This protocol tests de-escalated adjuvant treatment in patients with POLE-mutated or p53wt/NSMP (p53 wildtype/no specific molecular profile) early-stage endometrial cancer (EC). Patients may be enrolled in one of two sub-studies * EN10.A/RAINBO BLUE: POLE-mutated EC * EN10.B/TAPER: p53 wildtype / NSMP EC
This description comes directly from the study's public registry record.
Wendy Parulekar · 613-533-6430 · wparulekar@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| Alaska Womens Cancer Care | Anchorage, Alaska, United States | Recruiting |
| University of Arizona Cancer Center | Tucson, Arizona, United States | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Huntington Memorial Hospital | Pasadena, California, United States | Recruiting |
| Sutter Medical Center Sacramento | Sacramento, California, United States | Recruiting |
| UCHealth University of Colorado Hospital | Aurora, Colorado, United States | Recruiting |
| AdventHealth Porter | Denver, Colorado, United States | Recruiting |
| University of Florida | Gainesville, Florida, United States | Recruiting |
| University of Miami School of Medicine | Miami, Florida, United States | Recruiting |
| Sarasota Memorial Hospital - Venice | N. Venice, Florida, United States | Recruiting |
| Florida Cancer Specialists - Sarasota Downtown | Sarasota, Florida, United States | Recruiting |
| First Physicians Group-Sarasota | Sarasota, Florida, United States | Recruiting |
+ 102 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05640999